Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Staple Line Reinforcement

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07250373Not ApplicableActive Not Recruiting

Serratus Posterior Superior Intercostal Plane (SPSIP) Block Versus Intercostal Nerve (ICN) Block in Patients Undergoing Uniportal-VATS.

NCT04544865Not ApplicableCompleted

Study of ECHELON ENDOPATH(TM) Staple Line Reinforcement

Showing all 2 trials

Research Network

Common Treatments

  • Staple Line Reinforcement1
  • Icn Block1
  • Spsip Block1

Active Sponsors

  • Ethicon Endo-Surgery1
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Top Investigators

Related Conditions

  • Gastric Procedures1
  • Intercostal Nerve Block1
  • Serratus Posterior Superior Intercostal Plane Block1
  • Uniportal Video Assisted Thoracic Surgery1
  • Locoregional Anesthesia1

Activity Timeline